Binding of Complement Factor H to Endothelial Cells Is Mediated by the Carboxy-Terminal Glycosaminoglycan Binding Site
- 1 October 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 167 (4), 1173-1181
- https://doi.org/10.1016/s0002-9440(10)61205-9
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countriesJournal of Medical Genetics, 2003
- Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritisClinical and Experimental Immunology, 2003
- Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor HNature Genetics, 2002
- Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraKidney International, 2001
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell RecognitionAmerican Journal of Human Genetics, 2001
- Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3bJournal of Biological Chemistry, 2000
- Regulation of Alternative Pathway Complement Activation by Glycosaminoglycans: Specificity of the Polyanion Binding Site on Factor HBiochemical and Biophysical Research Communications, 1994
- Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.The Journal of Experimental Medicine, 1992
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965